Background: Most noninvasive predictive models of liver fibrosis are complicated and have suboptimal sensitivity. This study was designed to identify serum proteomic signatures associated with liver fibrosis and to develop a proteome-based fingerprinting model for prediction of liver fibrosis. Methods: Serum proteins from 46 patients with chronic hepatitis B (CHB) were profiled quantitatively on sur-face-enhanced laser desorption/ionization (SELDI) Pro-teinChip arrays. The identified liver fibrosis-associated proteomic fingerprint was used to construct an artificial neural network (ANN) model that produced a fibrosis index with a range of 0–6. The clinical value of this index was evaluated by leave-one-out cross-validation. Results: Thirty ...
BACKGROUND: Liver biopsy is currently the gold standard for assessing liver fibrosis, and no reliabl...
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic f...
Abstract Background Liver fibrosis progression is commonly found in patients with CHB. Liver biopsy ...
Cilj: Većina neinvazivnih metoda (modela) za predikciju i dijagnosti ciranje jetrene ciroze komplici...
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic f...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive dia...
The inventors have proposed a novel panel of human plasma protein biomarkers for diagnosing hepatic ...
Introduction: Liver biopsy is the reference standard for assessing liver fibrosis, and no reliable n...
Proteomics can help to discover and quantify novel biomarkers and we show how this is achieved using...
Chronic liver disease (CLD) is a major and growing healthcare burden but is asymptomatic until liver...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable serum biomarkers...
Liver fibrosis is a serious health issue for many liver patients and is currently diagnosed using li...
A non-invasive diagnostic approach is crucial for the evaluation of severity of liver disease, treat...
Liver biopsy is an imperfect standard for the assessment of chronic hepatitis C liver fibrosis. In t...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive dia...
BACKGROUND: Liver biopsy is currently the gold standard for assessing liver fibrosis, and no reliabl...
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic f...
Abstract Background Liver fibrosis progression is commonly found in patients with CHB. Liver biopsy ...
Cilj: Većina neinvazivnih metoda (modela) za predikciju i dijagnosti ciranje jetrene ciroze komplici...
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic f...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive dia...
The inventors have proposed a novel panel of human plasma protein biomarkers for diagnosing hepatic ...
Introduction: Liver biopsy is the reference standard for assessing liver fibrosis, and no reliable n...
Proteomics can help to discover and quantify novel biomarkers and we show how this is achieved using...
Chronic liver disease (CLD) is a major and growing healthcare burden but is asymptomatic until liver...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable serum biomarkers...
Liver fibrosis is a serious health issue for many liver patients and is currently diagnosed using li...
A non-invasive diagnostic approach is crucial for the evaluation of severity of liver disease, treat...
Liver biopsy is an imperfect standard for the assessment of chronic hepatitis C liver fibrosis. In t...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive dia...
BACKGROUND: Liver biopsy is currently the gold standard for assessing liver fibrosis, and no reliabl...
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic f...
Abstract Background Liver fibrosis progression is commonly found in patients with CHB. Liver biopsy ...